Central Nervous System Therapeutics Market Share

Statistics for the 2023 & 2024 Central Nervous System Therapeutics market share, created by Mordor Intelligence™ Industry Reports. Central Nervous System Therapeutics share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Central Nervous System Therapeutics Industry

The central nervous system therapeutics market is highly competitive, with several market players. However, the need for innovation in the treatment and drug delivery system, clinical trials, and strategic collaboration is likely to help companies maintain their market position. Some of the key companies in the market are Biogen Inc, Eli Lilly and Company, Novartis AG, Johnson & Johnson, Pfizer Inc., and GSK plc, among others.

Central Nervous System Therapeutics Market Leaders

  1. Biogen

  2. Novartis AG

  3. Merck KGaA

  4. Eli Lilly and Company

  5. Johnson & Johnson

*Disclaimer: Major Players sorted in no particular order

Central Nervous System Therapeutics Market Concentration

Central Nervous System Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)